Stavroula Pallada
Id
6392996088{"id":7844064,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":25010,"title":"LTA 2025.","description":"Hepia et Unige unissent leurs efforts afin de cr\u00e9er le Laboratoire de Technologie Avanc\u00e9e, ci-apr\u00e8s LTA, une infrastructure con\u00e7ue pour valoriser le savoir-faire et les \u00e9quipements de pointe de l'Universit\u00e9 de Gen\u00e8ve et de la HES-SO Gen\u00e8ve aupr\u00e8s des industries. Porte d'entr\u00e9e vers pr\u00e8s de 20 groupes de recherche et plus de 100 \u00e9quipements et savoir-faire, le LTA apporte des solutions techniques originales aux petites, moyennes et grandes entreprises.\r\n\r\nObjectifs :\r\n\r\nPar la cr\u00e9ation du LTA, . Hepia et Unige entendent :\r\na) proposer des mandats de prestations et mettre \u00e0 disposition des initiatives individuelles (acad\u00e9miques ou industrielles) des comp\u00e9tences et des technologies de haut niveau pr\u00e9sentes aupr\u00e8s des hautes \u00e9coles susmentionn\u00e9es ;\r\nb) valoriser les laboratoires existants et rendre tout nouvel investissement efficient ;\r\nc) offrir un guichet unique aux entreprises et leur facilit\u00e9 l'acc\u00e8s aux \u00e9quipements et aux groupes de recherche.\r\n"},"en":{"id":25011,"title":"LTA 2025.","description":"Hepia et Unige unissent leurs efforts afin de cr\u00e9er le Laboratoire de Technologie Avanc\u00e9e, ci-apr\u00e8s LTA, une infrastructure con\u00e7ue pour valoriser le savoir-faire et les \u00e9quipements de pointe de l'Universit\u00e9 de Gen\u00e8ve et de la HES-SO Gen\u00e8ve aupr\u00e8s des industries. Porte d'entr\u00e9e vers pr\u00e8s de 20 groupes de recherche et plus de 100 \u00e9quipements et savoir-faire, le LTA apporte des solutions techniques originales aux petites, moyennes et grandes entreprises.\r\n\r\nObjectifs :\r\n\r\nPar la cr\u00e9ation du LTA, . Hepia et Unige entendent :\r\na) proposer des mandats de prestations et mettre \u00e0 disposition des initiatives individuelles (acad\u00e9miques ou industrielles) des comp\u00e9tences et des technologies de haut niveau pr\u00e9sentes aupr\u00e8s des hautes \u00e9coles susmentionn\u00e9es ;\r\nb) valoriser les laboratoires existants et rendre tout nouvel investissement efficient ;\r\nc) offrir un guichet unique aux entreprises et leur facilit\u00e9 l'acc\u00e8s aux \u00e9quipements et aux groupes de recherche.\r\n"},"de":{"id":25012,"title":"LTA 2025.","description":"Hepia et Unige unissent leurs efforts afin de cr\u00e9er le Laboratoire de Technologie Avanc\u00e9e, ci-apr\u00e8s LTA, une infrastructure con\u00e7ue pour valoriser le savoir-faire et les \u00e9quipements de pointe de l'Universit\u00e9 de Gen\u00e8ve et de la HES-SO Gen\u00e8ve aupr\u00e8s des industries. Porte d'entr\u00e9e vers pr\u00e8s de 20 groupes de recherche et plus de 100 \u00e9quipements et savoir-faire, le LTA apporte des solutions techniques originales aux petites, moyennes et grandes entreprises.\r\n\r\nObjectifs :\r\n\r\nPar la cr\u00e9ation du LTA, . Hepia et Unige entendent :\r\na) proposer des mandats de prestations et mettre \u00e0 disposition des initiatives individuelles (acad\u00e9miques ou industrielles) des comp\u00e9tences et des technologies de haut niveau pr\u00e9sentes aupr\u00e8s des hautes \u00e9coles susmentionn\u00e9es ;\r\nb) valoriser les laboratoires existants et rendre tout nouvel investissement efficient ;\r\nc) offrir un guichet unique aux entreprises et leur facilit\u00e9 l'acc\u00e8s aux \u00e9quipements et aux groupes de recherche.\r\n"}},"id":135144,"acronym":"LTA_2025","mainTitle":"LTA 2025.","mainDescription":"Hepia et Unige unissent leurs efforts afin de cr\u00e9er le Laboratoire de Technologie Avanc\u00e9e, ci-apr\u00e8s LTA, une infrastructure con\u00e7ue pour valoriser le savoir-faire et les \u00e9quipements de pointe de l'Universit\u00e9 de Gen\u00e8ve et de la HES-SO Gen\u00e8ve aupr\u00e8s des industries. Porte d'entr\u00e9e vers pr\u00e8s de 20 groupes de recherche et plus de 100 \u00e9quipements et savoir-faire, le LTA apporte des solutions techniques originales aux petites, moyennes et grandes entreprises.\r\n\r\nObjectifs :\r\n\r\nPar la cr\u00e9ation du LTA, . Hepia et Unige entendent :\r\na) proposer des mandats de prestations et mettre \u00e0 disposition des initiatives individuelles (acad\u00e9miques ou industrielles) des comp\u00e9tences et des technologies de haut niveau pr\u00e9sentes aupr\u00e8s des hautes \u00e9coles susmentionn\u00e9es ;\r\nb) valoriser les laboratoires existants et rendre tout nouvel investissement efficient ;\r\nc) offrir un guichet unique aux entreprises et leur facilit\u00e9 l'acc\u00e8s aux \u00e9quipements et aux groupes de recherche.\r\n","value":"30336.60","finished":false,"pilier":5,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":1857270,"name":"","confidential":false,"types":[{"id":3,"code":"RP"},{"id":4,"code":"CO"}],"institution":"HEPIA inTECH","class":"academique"},{"id":1857271,"name":"Pallada Stavroula","confidential":false,"types":[{"id":3,"code":"RP"},{"id":4,"code":"CO"}],"institution":"HEPIA inTECH","class":"academique"}],"collaborators":[{"id":7844056,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"nicola.giandome","project":135144},{"id":7844057,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"dominiqu.trinchan","project":135144},{"id":7844058,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"mariecon.willemin","project":135144},{"id":7844059,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"malek.fedel","project":135144},{"id":7844060,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"patrick.haas","project":135144},{"id":7844061,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"martina.zselysch","project":135144},{"id":7844062,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"gilles.triscone","project":135144},{"id":7844063,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"christia.doimo","project":135144},{"id":7844064,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":135144},{"id":7844065,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"christop.balistre","project":135144},{"id":7844066,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"nicolas.stucki","project":135144}],"dataHub":true,"startAt":"2025-01-01T00:00:00+01:00","endAt":"2025-12-31T00:00:00+01:00","fundingSource":"Universit\u00e9 de Gen\u00e8ve","publications":[],"projectUrl":null,"repo_name":null}}{"id":7786072,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":24123,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RMD.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RMD."},"en":{"id":24124,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RMD.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RMD."},"de":{"id":24125,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RMD.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RMD."}},"id":132775,"acronym":"P3 - Prime Innosuisse - RMD","mainTitle":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RMD.","mainDescription":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RMD.","value":"15000.00","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":1842553,"name":"","confidential":false,"types":[{"id":3,"code":"RP"},{"id":4,"code":"CO"}],"institution":"HEPIA inTECH","class":"academique"}],"collaborators":[{"id":7786071,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"romain.boulande","project":132775},{"id":7786072,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":132775}],"dataHub":true,"startAt":"2024-06-10T00:00:00+02:00","endAt":"2025-12-31T00:00:00+01:00","fundingSource":"HES-SO Rectorat","publications":[],"projectUrl":null,"repo_name":null}}{"id":7784839,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":24096,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Etat de Gen\u00e8ve - Surveillance des mati\u00e8res radioactives.\r\n","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Etat de Gen\u00e8ve - Surveillance des mati\u00e8res radioactives."},"en":{"id":24097,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Etat de Gen\u00e8ve - Surveillance des mati\u00e8res radioactives.\r\n","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Etat de Gen\u00e8ve - Surveillance des mati\u00e8res radioactives."},"de":{"id":24098,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Etat de Gen\u00e8ve - Surveillance des mati\u00e8res radioactives.\r\n","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Etat de Gen\u00e8ve - Surveillance des mati\u00e8res radioactives."}},"id":132638,"acronym":"P7 - Prime Etat de Gen\u00e8ve - Surv. mat. radioact.","mainTitle":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Etat de Gen\u00e8ve - Surveillance des mati\u00e8res radioactives.\r\n","mainDescription":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Etat de Gen\u00e8ve - Surveillance des mati\u00e8res radioactives.","value":"7500.00","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":1842180,"name":"","confidential":false,"types":[{"id":3,"code":"RP"},{"id":4,"code":"CO"}],"institution":"HEPIA inTECH","class":"academique"}],"collaborators":[{"id":7784839,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":132638}],"dataHub":true,"startAt":"2024-06-04T00:00:00+02:00","endAt":"2025-12-31T00:00:00+01:00","fundingSource":"HES-SO Rectorat","publications":[],"projectUrl":null,"repo_name":null}}{"id":7782495,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":22155,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - ECT4AMM.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers."},"en":{"id":22156,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - ECT4AMM.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers."},"de":{"id":22157,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - ECT4AMM.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers."}},"id":126292,"acronym":"P3 - Prime Innosuisse - ECT4AMM","mainTitle":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - ECT4AMM.","mainDescription":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers.","value":"15000.00","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":1841544,"name":"","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"VS - Institut Syst\u00e8mes industriels","class":"academique"},{"id":1841545,"name":"","confidential":false,"types":[{"id":3,"code":"RP"},{"id":4,"code":"CO"}],"institution":"HEPIA inTECH","class":"academique"}],"collaborators":[{"id":7782492,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"jacques.richard","project":126292},{"id":7782493,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"gilles.triscone","project":126292},{"id":7782494,"role":"RP","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"flavio.noca","project":126292},{"id":7782495,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":126292},{"id":7782496,"role":"CO","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"samuel.reymerme","project":126292}],"dataHub":true,"startAt":"2023-05-11T00:00:00+02:00","endAt":"2025-12-31T00:00:00+01:00","fundingSource":"HES-SO Rectorat","publications":[],"projectUrl":null,"repo_name":null}}{"id":7779414,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":22146,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RadonMitigationDosimetry.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers."},"en":{"id":22147,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RadonMitigationDosimetry.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers."},"de":{"id":22148,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RadonMitigationDosimetry.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers."}},"id":126385,"acronym":"P3 - Prime Innosuisse - RadonMitigationDosimetry","mainTitle":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - RadonMitigationDosimetry.","mainDescription":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers.","value":"7500.00","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":1840625,"name":"","confidential":false,"types":[{"id":3,"code":"RP"},{"id":4,"code":"CO"}],"institution":"HEPIA inTECH","class":"academique"}],"collaborators":[{"id":7779413,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"gilles.triscone","project":126385},{"id":7779414,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":126385},{"id":7779415,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"hugo.corcelle","project":126385}],"dataHub":true,"startAt":"2023-05-11T00:00:00+02:00","endAt":"2025-12-31T00:00:00+01:00","fundingSource":"HES-SO Rectorat","publications":[],"projectUrl":null,"repo_name":null}}{"id":7776353,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":24003,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - BAUDINDUSTRIES.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - BAUDINDUSTRIES."},"en":{"id":24004,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - BAUDINDUSTRIES.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - BAUDINDUSTRIES."},"de":{"id":24005,"title":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - BAUDINDUSTRIES.","description":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - BAUDINDUSTRIES."}},"id":132777,"acronym":"P3 - Prime Innosuisse - BAUDINDUSTRIES","mainTitle":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - BAUDINDUSTRIES.","mainDescription":"Programme de soutien au d\u00e9p\u00f4t de projets li\u00e9s \u00e0 l'obtention de fonds de tiers ; Prime Innosuisse - BAUDINDUSTRIES.","value":"7500.00","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":1839784,"name":"","confidential":false,"types":[{"id":3,"code":"RP"},{"id":4,"code":"CO"}],"institution":"HEPIA inTECH","class":"academique"}],"collaborators":[{"id":7776352,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"gilles.triscone","project":132777},{"id":7776353,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":132777}],"dataHub":true,"startAt":"2024-06-10T00:00:00+02:00","endAt":"2025-12-31T00:00:00+01:00","fundingSource":"HES-SO Rectorat","publications":[],"projectUrl":null,"repo_name":null}}{"id":4270634,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":23456,"title":"Geneva HIT Institute","description":"HEPIA propose une formation HES Bachelor dans les domaines de la radioprotection, du nucléaire appliqué
\r\net de l'imagerie médicale, dans la filière Microtechniques orientation ingénieur de recherche.
\r\nL'enseignement de ce type de compétences n'est pas récent étant donné qu'elles ont déjà été proposées
\r\ndans les années septante. Toutefois, c'est surtout le fait de disposer de laboratoires nucléaires de type B,
\r\nuniques en HES et rares dans les Universités et centres de recherche suisses, qui fait la particularité d'HEPIA dans ce domaine.
\r\nLa HEdS propose la filière Technique en radiologie médicale dont les bachelières et bacheliers doivent également présenter des compétences en radioprotection, nucléaire appliqué et imagerie médicale dans le cadre de l'exercice journalier de leur profession. Cette filière forme des professionnels de la santé
\r\nessentiels au fonctionnement des services d'imagerie médicale et de radioconcologie des hôpitaux et centres de radiologie privés.
\r\nPar conséquent, les enseignant-e-s des deux filières issues des deux écoles se sont naturellement rapprochés et ont commencé depuis plusieurs années à échanger, puis à collaborer de manière active et créative en matière d'enseignement et de recherche.
\r\nLes objectifs de cette proposition de création d'un institut entre Hepia et la HEdS à la HES-SO Genève sont de favoriser des activités de recherche inter domaine, ainsi que d'ancrer et renforcer les compétences communes sur le long terme mais aussi d'étendre la collaboration entre les deux écoles à d'autres secteurs
\r\ncomme par exemple celui de la santé digitale. La création de cet institut, qui s'appuiera notamment sur la
\r\ncréation d`un laboratoire commun aux deux Écoles, vise également à valoriser nos compétences HES et
\r\nd'augmenter notre visibilité au niveau lémanique et au-delà.
\r\nMalgré le fait que depuis plusieurs années les deux Hautes Écoles collaborent, la visibilité de cette montée
\r\nen compétences doit être accrue. En effet, probablement pour des raisons de disponibilités des uns et des
\r\nautres et le fait d'avoir de nombreux projets en cours, les actions de communication n'ont souvent pas été
\r\nà la hauteur des travaux effectifs.
\r\nLes directions des deux écoles souhaitent consolider ces potentialités et définir une stratégie basée sur
\r\nune vision d'avenir. Elles peuvent s'appuyer sur une équipe de professeur.e.s de haut niveau et qui
\r\ntravaillent déjà ensemble. <\/p>"}},"id":1086412,"acronym":null,"mainTitle":"Geneva HIT Institute","mainDescription":"
HEPIA propose une formation HES Bachelor dans les domaines de la radioprotection, du nucléaire appliqué
\r\net de l'imagerie médicale, dans la filière Microtechniques orientation ingénieur de recherche.
\r\nL'enseignement de ce type de compétences n'est pas récent étant donné qu'elles ont déjà été proposées
\r\ndans les années septante. Toutefois, c'est surtout le fait de disposer de laboratoires nucléaires de type B,
\r\nuniques en HES et rares dans les Universités et centres de recherche suisses, qui fait la particularité d'HEPIA dans ce domaine.
\r\nLa HEdS propose la filière Technique en radiologie médicale dont les bachelières et bacheliers doivent également présenter des compétences en radioprotection, nucléaire appliqué et imagerie médicale dans le cadre de l'exercice journalier de leur profession. Cette filière forme des professionnels de la santé
\r\nessentiels au fonctionnement des services d'imagerie médicale et de radioconcologie des hôpitaux et centres de radiologie privés.
\r\nPar conséquent, les enseignant-e-s des deux filières issues des deux écoles se sont naturellement rapprochés et ont commencé depuis plusieurs années à échanger, puis à collaborer de manière active et créative en matière d'enseignement et de recherche.
\r\nLes objectifs de cette proposition de création d'un institut entre Hepia et la HEdS à la HES-SO Genève sont de favoriser des activités de recherche inter domaine, ainsi que d'ancrer et renforcer les compétences communes sur le long terme mais aussi d'étendre la collaboration entre les deux écoles à d'autres secteurs
\r\ncomme par exemple celui de la santé digitale. La création de cet institut, qui s'appuiera notamment sur la
\r\ncréation d`un laboratoire commun aux deux Écoles, vise également à valoriser nos compétences HES et
\r\nd'augmenter notre visibilité au niveau lémanique et au-delà.
\r\nMalgré le fait que depuis plusieurs années les deux Hautes Écoles collaborent, la visibilité de cette montée
\r\nen compétences doit être accrue. En effet, probablement pour des raisons de disponibilités des uns et des
\r\nautres et le fait d'avoir de nombreux projets en cours, les actions de communication n'ont souvent pas été
\r\nà la hauteur des travaux effectifs.
\r\nLes directions des deux écoles souhaitent consolider ces potentialités et définir une stratégie basée sur
\r\nune vision d'avenir. Elles peuvent s'appuyer sur une équipe de professeur.e.s de haut niveau et qui
\r\ntravaillent déjà ensemble. <\/p>","value":"960000","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[],"collaborators":[{"id":4270634,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":1086412},{"id":4270635,"role":"RP","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"gilles.triscone","project":1086412},{"id":4270636,"role":"CO","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"jerome.schmid","project":1086412},{"id":4270637,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"ashley.cooper","project":1086412}],"dataHub":false,"startAt":"2021-04-01T00:00:00+02:00","endAt":"2026-12-31T00:00:00+01:00","fundingSource":"HES-SO","publications":[],"projectUrl":null,"repo_name":null}}
{"id":4270632,"role":"RP","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":23455,"title":"Radon mitigation and dosimetry","description":"Le radon est un gaz naturel radioactif présent dans les sols contenant de l’uranium. Si le sol est poreux, il peut alors se déplacer et s'en échapper. En hiver, lorsque les habitations sont chauffées, il peut s'accumuler dans les bâtiments et devenir un problème de santé publique. Notons que ce n’est pas le radon, gaz noble, qui est dangereux mais ses descendants qui, une fois inhalés, se déposent dans les poumons et peuvent potentiellement représenter une cause directe de cancer du poumon. <\/p>\r\n\r\n
Le radon est la deuxième cause de cancer du poumon après le tabagisme. Dans le monde, il est source de centaines milliers de cancers chaque année. En janvier 2018, la directive 2013\/59\/Euratom du Conseil de l'UE est entrée en vigueur dans l'UE et en Suisse. Les limites légales de concentration intérieure en radon ont été abaissées d'un facteur 10 pour les lieux de travail et d'un facteur 3 pour les écoles et les habitations. En Europe, des millions de bâtiments ne sont plus conformes et nécessitent des travaux pour être conformes aux normes en vigueur. L'objectif de ce projet était de travailler sur une solution innovante, qui traite directement de la dose radioactive pour le poumon (c'est-à-dire la cause réelle du cancer) plutôt que de la concentration de radon. Cette solution s'appuie sur des dispositifs de purification de l’air à l’aide de filtres spéciaux ; le tout monitoré par des détecteurs RaDoM développés par une spin-off du CERN qui fournissent en temps réel une évaluation directe de la dose au poumon. <\/p>"}},"id":1025606,"acronym":null,"mainTitle":"Radon mitigation and dosimetry","mainDescription":"
Le radon est un gaz naturel radioactif présent dans les sols contenant de l’uranium. Si le sol est poreux, il peut alors se déplacer et s'en échapper. En hiver, lorsque les habitations sont chauffées, il peut s'accumuler dans les bâtiments et devenir un problème de santé publique. Notons que ce n’est pas le radon, gaz noble, qui est dangereux mais ses descendants qui, une fois inhalés, se déposent dans les poumons et peuvent potentiellement représenter une cause directe de cancer du poumon. <\/p>\r\n\r\n
Le radon est la deuxième cause de cancer du poumon après le tabagisme. Dans le monde, il est source de centaines milliers de cancers chaque année. En janvier 2018, la directive 2013\/59\/Euratom du Conseil de l'UE est entrée en vigueur dans l'UE et en Suisse. Les limites légales de concentration intérieure en radon ont été abaissées d'un facteur 10 pour les lieux de travail et d'un facteur 3 pour les écoles et les habitations. En Europe, des millions de bâtiments ne sont plus conformes et nécessitent des travaux pour être conformes aux normes en vigueur. L'objectif de ce projet était de travailler sur une solution innovante, qui traite directement de la dose radioactive pour le poumon (c'est-à-dire la cause réelle du cancer) plutôt que de la concentration de radon. Cette solution s'appuie sur des dispositifs de purification de l’air à l’aide de filtres spéciaux ; le tout monitoré par des détecteurs RaDoM développés par une spin-off du CERN qui fournissent en temps réel une évaluation directe de la dose au poumon. <\/p>","value":"15000","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":970628,"name":"Alessandro Curioni","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"BAQ (suisse) Sarl","class":"professionnel"},{"id":970629,"name":"Stefano Romano","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"BAQ (suisse) Sarl","class":"professionnel"}],"collaborators":[{"id":4270632,"role":"RP","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":1025606},{"id":4270633,"role":"CO","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"gilles.triscone","project":1025606}],"dataHub":false,"startAt":null,"endAt":null,"fundingSource":"Ch\u00e8que Alliance","publications":[],"projectUrl":null,"repo_name":null}}
{"id":4270631,"role":"RP","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":23454,"title":"A novel in-vitro diagnostic paradigm: polymer mediated diagnostics for the detection of low- concentration biomarkers","description":"Biomarkers used in medicine, are a measurable indicator of some biological states or conditions and are a part of a relatively new clinical toolset categorised by their clinical applications. Their clinical role is in narrowing or guiding treatment decisions and follow a sub-categorization of being either predictive, prognostic or diagnostic. Biomarkers are often measured and evaluated using blood, urine or soft tissue to examine normal biological processes, pathogenic processes or pharmacologic responses to a therapeutic intervention.<\/p>\r\n\r\n
Tuberculosis (TB) is a widespread condition that is even coming back to our regions. The current test techniques are based on an invasive procedure, a sputum test. A strategy has been developed for a triage test from blood, which abides the World Health Organisation’s target product profile (TPP) [1]. The four biomarkers that have been identified allowing for a TB triage test are IL-6, IL-8, IL-18 and VEGF. However, heavy and bulky equipment is needed to measure these biomarkers in their respective concentrations.<\/p>\r\n\r\n
The ultimate goal of current endeavours to improve TB triage tests is to use a technique that can be performed at point-of-care in any endemic region, or any region for that matter. For achieving this objective, we have to take tackle the following unmet diagnostic needs:
\r\nI) A sub pg\/ml detection limit<\/p>\r\n\r\n
II) Fast and spontaneous signal generation iii) Cost-effectiveness of the technique<\/p>"}},"id":1069763,"acronym":null,"mainTitle":"A novel in-vitro diagnostic paradigm: polymer mediated diagnostics for the detection of low- concentration biomarkers","mainDescription":"
Biomarkers used in medicine, are a measurable indicator of some biological states or conditions and are a part of a relatively new clinical toolset categorised by their clinical applications. Their clinical role is in narrowing or guiding treatment decisions and follow a sub-categorization of being either predictive, prognostic or diagnostic. Biomarkers are often measured and evaluated using blood, urine or soft tissue to examine normal biological processes, pathogenic processes or pharmacologic responses to a therapeutic intervention.<\/p>\r\n\r\n
Tuberculosis (TB) is a widespread condition that is even coming back to our regions. The current test techniques are based on an invasive procedure, a sputum test. A strategy has been developed for a triage test from blood, which abides the World Health Organisation’s target product profile (TPP) [1]. The four biomarkers that have been identified allowing for a TB triage test are IL-6, IL-8, IL-18 and VEGF. However, heavy and bulky equipment is needed to measure these biomarkers in their respective concentrations.<\/p>\r\n\r\n
The ultimate goal of current endeavours to improve TB triage tests is to use a technique that can be performed at point-of-care in any endemic region, or any region for that matter. For achieving this objective, we have to take tackle the following unmet diagnostic needs:
\r\nI) A sub pg\/ml detection limit<\/p>\r\n\r\n
II) Fast and spontaneous signal generation iii) Cost-effectiveness of the technique<\/p>","value":"46000","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":970627,"name":"Kandaswamy Djano","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"AeChem Life Technologies","class":"professionnel"}],"collaborators":[{"id":4270631,"role":"RP","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":1069763}],"dataHub":false,"startAt":"2024-01-01T00:00:00+01:00","endAt":"2025-01-31T00:00:00+01:00","fundingSource":"OPI cheque","publications":[],"projectUrl":null,"repo_name":null}}
{"id":4270629,"role":"ME","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":23453,"title":"Projet Microbials: Des algues unicellulaires comme agents de bio-rem\u00e9diation du strontium 90?","description":"Le strontium 90 est un radionucléide d’origine artificielle émis lors d’accidents d’installations nucléaires (Tchernobyl, Fukushima Daiichi) et des essais nucléaires militaires (Pacifique Sud, Semipalatinsk). Il entre aussi, pour une faible part, dans les rejets d’effluents des centrales nucléaires et, en proportion plus grande, dans les effluents liquides des usines de retraitement (La Hague, Sellafield). Le strontium 90 est radiotoxique; en raison de ses similitudes chimiques et biochimiques avec le calcium, plus de 99% du strontium dans les organismes vivants existe dans les os et les dents. L'exposition interne à long terme par le strontium 90 accumulé et son radionucléide descendant, l'yttrium 90, augmente le risque de leucémie et de cancer du squelette.<\/p>\r\n\r\n
Des expériences avec des cultures de laboratoire enrichies avec des isotopes stables de strontium ont démontré que certains microorganismes incorporent efficacement cet élément étant ainsi capables de diminuer significativement sa concentration dans le milieu de culture. En particulier, certaines espèces de microalgues vertes de la classe des Chlorodendrophycées sont des candidates potentielles pour le développement de nouvelles techniques de bio-remédiation du strontium : celles-ci auraient lieu via la formation d’inclusions intracellulaires de carbonate de calcium amorphe enrichies en strontium. <\/p>\r\n\r\n
Ce projet cherche à vérifier si ces algues, déjà testées en laboratoire avec des isotopes stables de strontium, sont aussi capables d’accumuler le strontium 90 en présence de concentrations naturelles des isotopes stables et si cette accumulation permettrait d’envisager leur utilisation comme méthode de bioremédiation.<\/p>"}},"id":1042732,"acronym":null,"mainTitle":"Projet Microbials: Des algues unicellulaires comme agents de bio-rem\u00e9diation du strontium 90?","mainDescription":"
Le strontium 90 est un radionucléide d’origine artificielle émis lors d’accidents d’installations nucléaires (Tchernobyl, Fukushima Daiichi) et des essais nucléaires militaires (Pacifique Sud, Semipalatinsk). Il entre aussi, pour une faible part, dans les rejets d’effluents des centrales nucléaires et, en proportion plus grande, dans les effluents liquides des usines de retraitement (La Hague, Sellafield). Le strontium 90 est radiotoxique; en raison de ses similitudes chimiques et biochimiques avec le calcium, plus de 99% du strontium dans les organismes vivants existe dans les os et les dents. L'exposition interne à long terme par le strontium 90 accumulé et son radionucléide descendant, l'yttrium 90, augmente le risque de leucémie et de cancer du squelette.<\/p>\r\n\r\n
Des expériences avec des cultures de laboratoire enrichies avec des isotopes stables de strontium ont démontré que certains microorganismes incorporent efficacement cet élément étant ainsi capables de diminuer significativement sa concentration dans le milieu de culture. En particulier, certaines espèces de microalgues vertes de la classe des Chlorodendrophycées sont des candidates potentielles pour le développement de nouvelles techniques de bio-remédiation du strontium : celles-ci auraient lieu via la formation d’inclusions intracellulaires de carbonate de calcium amorphe enrichies en strontium. <\/p>\r\n\r\n
Ce projet cherche à vérifier si ces algues, déjà testées en laboratoire avec des isotopes stables de strontium, sont aussi capables d’accumuler le strontium 90 en présence de concentrations naturelles des isotopes stables et si cette accumulation permettrait d’envisager leur utilisation comme méthode de bioremédiation.<\/p>","value":null,"finished":true,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[],"collaborators":[{"id":4270629,"role":"ME","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":1042732},{"id":4270630,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"anastasi.kanellak","project":1042732}],"dataHub":false,"startAt":null,"endAt":"2023-09-30T00:00:00+02:00","fundingSource":"Gebert R\u00fcf Stiftung (B\u00e2le, Suisse)","publications":[],"projectUrl":"https:\/\/pubs.rsc.org\/en\/content\/articlehtml\/2024\/em\/d3em00336a","repo_name":null}}
{"id":4270627,"role":"CO","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":23452,"title":"Radon Mitigation and Dosimetry","description":"Radon is a natural radioactive gas and the second leading cause of lung cancer, after smoking. This project targets the development of a novel mitigation technique for radon, and related radon dosimetry, able to offer a convenient alternative to existing mitigation techniques.<\/p>"}},"id":1060375,"acronym":null,"mainTitle":"Radon Mitigation and Dosimetry","mainDescription":"
Radon is a natural radioactive gas and the second leading cause of lung cancer, after smoking. This project targets the development of a novel mitigation technique for radon, and related radon dosimetry, able to offer a convenient alternative to existing mitigation techniques.<\/p>","value":"161360.65","finished":true,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":970625,"name":"Alessandro Curioni","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"BAQ (Suisse) S\u00e0rl","class":"professionnel"},{"id":970626,"name":"Stefano Romano","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"BAQ (Suisse) S\u00e0rl","class":"professionnel"}],"collaborators":[{"id":4270627,"role":"CO","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":1060375},{"id":4270628,"role":"CO","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"gilles.triscone","project":1060375}],"dataHub":false,"startAt":"2023-09-01T00:00:00+02:00","endAt":"2025-02-28T00:00:00+01:00","fundingSource":"Innosuisse","publications":[],"projectUrl":null,"repo_name":null}}
{"id":4270622,"role":"RP","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":23451,"title":"GAMMA-MRI: the future of molecular imaging","description":"Gamma-MRI will develop a clinical molecular imaging device based on the physical principle of anisotropic gamma emission from hyperpolarised metastable xenon. In the strategic move from “one size fits all” to personalised medicine, molecular imaging plays an essential role. However, despite significant technological advances in the last decades, medical imaging (especially for the brain) relies heavily on very expensive, complex and bulky machines. Moreover, MRI suffers from low sensitivity, only partially compensated by the recent advances in hyperpolarisation. On the other hand, the very sensitive PET and SPECT imaging modalities offer limited spatial resolution. Besides those trade-offs, the limited access to suitable devices still hinders the applicability of medical imaging to address major healthcare challenges in brain-related pathologies, even in Europe. Stroke alone is the second cause of death and the third cause of disability worldwide. The evolution of ischaemic damage varies much among patients. To achieve significant improvement in the outcome of the patients, a careful selection of the treatment path guided by images of the ischaemic brain, in a narrow time window of just a few hours is crucial. Unfortunately, point-of-care molecular imaging that could speed up patient management barely exists. Gamma-MRI is a game-changer imaging technology, combining the high sensitivity of gamma ray detection and the high resolution and flexibility of MRI, bringing down by multiple fold the cost of molecular imaging. Six closely interlinked work packages will cover: production of hyperpolarised gamma-emitting xenon isomers; preserving hyperpolarisation until delivery to targeted organ; developing advanced image acquisition and reconstruction using physics- and artificial intelligence- based approaches; designing and assembling the prototype upon a low field versatile magnet; and implementing the first preclinical Gamma-MRI brain imaging experiment.<\/p>"}},"id":1004334,"acronym":null,"mainTitle":"GAMMA-MRI: the future of molecular imaging","mainDescription":"
Gamma-MRI will develop a clinical molecular imaging device based on the physical principle of anisotropic gamma emission from hyperpolarised metastable xenon. In the strategic move from “one size fits all” to personalised medicine, molecular imaging plays an essential role. However, despite significant technological advances in the last decades, medical imaging (especially for the brain) relies heavily on very expensive, complex and bulky machines. Moreover, MRI suffers from low sensitivity, only partially compensated by the recent advances in hyperpolarisation. On the other hand, the very sensitive PET and SPECT imaging modalities offer limited spatial resolution. Besides those trade-offs, the limited access to suitable devices still hinders the applicability of medical imaging to address major healthcare challenges in brain-related pathologies, even in Europe. Stroke alone is the second cause of death and the third cause of disability worldwide. The evolution of ischaemic damage varies much among patients. To achieve significant improvement in the outcome of the patients, a careful selection of the treatment path guided by images of the ischaemic brain, in a narrow time window of just a few hours is crucial. Unfortunately, point-of-care molecular imaging that could speed up patient management barely exists. Gamma-MRI is a game-changer imaging technology, combining the high sensitivity of gamma ray detection and the high resolution and flexibility of MRI, bringing down by multiple fold the cost of molecular imaging. Six closely interlinked work packages will cover: production of hyperpolarised gamma-emitting xenon isomers; preserving hyperpolarisation until delivery to targeted organ; developing advanced image acquisition and reconstruction using physics- and artificial intelligence- based approaches; designing and assembling the prototype upon a low field versatile magnet; and implementing the first preclinical Gamma-MRI brain imaging experiment.<\/p>","value":"3372392.5","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[],"collaborators":[{"id":4270622,"role":"RP","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":1004334},{"id":4270623,"role":"ME","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"nicola.giandome","project":1004334},{"id":4270624,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"anastasi.kanellak","project":1004334},{"id":4270625,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"quentin.rogliard","project":1004334},{"id":4270626,"role":"ME","display":false,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"ashley.cooper","project":1004334}],"dataHub":false,"startAt":"2021-05-01T00:00:00+02:00","endAt":"2024-09-30T00:00:00+02:00","fundingSource":"EUROPEAN INNOVATION COUNCIL AND SMES EXECUTIVE AGENCY (EISMEA)","publications":[],"projectUrl":"https:\/\/gamma-mri.eu","repo_name":null}}
{"id":341475,"role":"ME","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":{"translations":{"fr":{"id":17199,"title":"Radon mitigation and dosimetry","description":"Radon is a natural radioactive gas found in uranium\u2010rich and permeable soils. It escapes from the ground
\r\ninto the air and accumulates in buildings. When inhaled, radioactive radon progenies settle in the lungs and
\r\nbecome a direct cause of lung cancer. Radon is the second leading cause of lung cancer after smoking,
\r\nand more than one in ten cases are linked to radon: worldwide, this affects hundreds of thousands of
\r\npeople every year. In January 2018 the EU Council Directive 2013\/59\/Euratom entered into force in the EU
\r\nand in Switzerland. The legal limits for indoor radon concentration have been lowered by a factor of 10 for
\r\nworkplaces and by a factor of 3 for schools and homes. In Europe, millions of buildings are not compliant
\r\nand need radon mitigation. There are a number of situations in which invasive mitigation through building
\r\nrenovation is highly impractical, or flat impossible: for example, in historical buildings or in densely
\r\npopulated urban environments. In historical buildings it is often the case that HVAC systems are not
\r\npresent and cannot be installed. For these cases we have been working on an innovative solution, which
\r\ntackles directly the radioactive dose to the lung (i.e. the actual cause of cancer) rather than the radon
\r\nconcentration. This solution is based on existing devices designed for indoor air quality with improved
\r\nfilters, coupled to our RaDoM (Radon Dose Monitor) technology, which provides a direct assessment of the
\r\ndose to the lung in real-time.<\/p>"}},"id":1036913,"acronym":null,"mainTitle":"Radon mitigation and dosimetry","mainDescription":"
Radon is a natural radioactive gas found in uranium\u2010rich and permeable soils. It escapes from the ground
\r\ninto the air and accumulates in buildings. When inhaled, radioactive radon progenies settle in the lungs and
\r\nbecome a direct cause of lung cancer. Radon is the second leading cause of lung cancer after smoking,
\r\nand more than one in ten cases are linked to radon: worldwide, this affects hundreds of thousands of
\r\npeople every year. In January 2018 the EU Council Directive 2013\/59\/Euratom entered into force in the EU
\r\nand in Switzerland. The legal limits for indoor radon concentration have been lowered by a factor of 10 for
\r\nworkplaces and by a factor of 3 for schools and homes. In Europe, millions of buildings are not compliant
\r\nand need radon mitigation. There are a number of situations in which invasive mitigation through building
\r\nrenovation is highly impractical, or flat impossible: for example, in historical buildings or in densely
\r\npopulated urban environments. In historical buildings it is often the case that HVAC systems are not
\r\npresent and cannot be installed. For these cases we have been working on an innovative solution, which
\r\ntackles directly the radioactive dose to the lung (i.e. the actual cause of cancer) rather than the radon
\r\nconcentration. This solution is based on existing devices designed for indoor air quality with improved
\r\nfilters, coupled to our RaDoM (Radon Dose Monitor) technology, which provides a direct assessment of the
\r\ndose to the lung in real-time.<\/p>","value":"15000","finished":false,"pilier":6,"url":null,"keywords":null,"disciplines":[],"axes":[],"partners":[{"id":104639,"name":"Alessandro Curioni","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"BAQ Sarl (Suisse)","class":"professionnel"},{"id":104640,"name":"Stefano Romano","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"BAQ Sarl (Suisse)","class":"professionnel"},{"id":970624,"name":"Gilles Triscone","confidential":false,"types":[{"id":4,"code":"CO"}],"institution":"HEPIA","class":"academique"}],"collaborators":[{"id":341475,"role":"ME","display":true,"displayRole":true,"displayFinancialPartner":true,"displayAcademicPartner":true,"displayProfessionalPartner":true,"collaborator":"stavroul.pallada","project":1036913}],"dataHub":false,"startAt":null,"endAt":null,"fundingSource":"Innovation Cheque","publications":[],"projectUrl":null,"repo_name":null}}
[{"id":11686028200,"position":-1,"master":1,"function":"Professeur-e HES associ\u00e9-e","title":null,"email":"stavroula.pallada@hesge.ch","display":true,"jobLocation":"B204","phone":"+41 22 558 66 16","phoneVisible":false,"employer":{"translations":{"fr":{"id":23,"name":"Haute \u00e9cole du paysage, d'ing\u00e9nierie et d'architecture de Gen\u00e8ve"}},"id":561,"ldapId":"RORG-HEGE-EPIA","abbreviation":"hepia","link":"http:\/\/www.hesge.ch\/hepia","mail":"RHHEPIA@hesge.ch ","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/logo_hepia-ge.png","gmap":"46.209551, 6.135261","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1054,"type":"adressePrincipale","street":"Rue de la Prairie 4","officeBox":"","country":"CH","city":"1202 Gen\u00e8ve"}],"mainDomain":null,"secondaryDomain":null,"programs":[{"id":15,"empty":false,"name":"BSc HES-SO en Microtechniques"},{"id":22,"empty":false,"name":"BSc HES-SO en G\u00e9nie m\u00e9canique"},{"id":24,"empty":false,"name":"BSc HES-SO en G\u00e9nie civil"},{"id":26,"empty":false,"name":"BA HES-SO en Architecture"},{"id":49,"empty":false,"name":"BSc HES-SO en Technique des b\u00e2timents"},{"id":50,"empty":false,"name":"BSc HES-SO en Ing\u00e9nierie des technologies de l'information"},{"id":51,"empty":false,"name":"BSc HES-SO en Gestion de la nature"},{"id":52,"empty":false,"name":"BSc HES-SO en Architecture du paysage"},{"id":53,"empty":false,"name":"BSc HES-SO en Agronomie"},{"id":79,"empty":false,"name":"BSC HES-SO en Informatique et syst\u00e8mes de communication"},{"id":80,"empty":false,"name":"BSc en Informatique et syst\u00e8mes de communication"}]},"instituts":[],"service":{"translations":{"fr":{"id":23,"name":"Haute \u00e9cole du paysage, d'ing\u00e9nierie et d'architecture de Gen\u00e8ve"}},"id":561,"ldapId":"RORG-HEGE-EPIA","abbreviation":"hepia","link":"http:\/\/www.hesge.ch\/hepia","mail":"RHHEPIA@hesge.ch ","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/logo_hepia-ge.png","gmap":"46.209551, 6.135261","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1054,"type":"adressePrincipale","street":"Rue de la Prairie 4","officeBox":"","country":"CH","city":"1202 Gen\u00e8ve"}],"mainDomain":null,"secondaryDomain":null,"programs":[{"id":15,"empty":false,"name":"BSc HES-SO en Microtechniques"},{"id":22,"empty":false,"name":"BSc HES-SO en G\u00e9nie m\u00e9canique"},{"id":24,"empty":false,"name":"BSc HES-SO en G\u00e9nie civil"},{"id":26,"empty":false,"name":"BA HES-SO en Architecture"},{"id":49,"empty":false,"name":"BSc HES-SO en Technique des b\u00e2timents"},{"id":50,"empty":false,"name":"BSc HES-SO en Ing\u00e9nierie des technologies de l'information"},{"id":51,"empty":false,"name":"BSc HES-SO en Gestion de la nature"},{"id":52,"empty":false,"name":"BSc HES-SO en Architecture du paysage"},{"id":53,"empty":false,"name":"BSc HES-SO en Agronomie"},{"id":79,"empty":false,"name":"BSC HES-SO en Informatique et syst\u00e8mes de communication"},{"id":80,"empty":false,"name":"BSc en Informatique et syst\u00e8mes de communication"}]},"serviceHesso":null,"branch":{"translations":{"fr":{"id":364,"name":"Microtechniques"}},"id":139430,"abbreviation":"MTEC","type":1,"ldapId":"RACA-TICO-MTEC","parent":{"translations":{"fr":{"id":637,"name":"Technique et IT"}},"id":56625318,"abbreviation":"TeIT","type":0,"ldapId":"RACA-TICO","parent":null}}},{"id":10873949140,"position":0,"master":0,"function":"Professeure HES assistante","title":null,"email":"stavroula.pallada@hesge.ch","display":true,"jobLocation":null,"phone":"+41 22 558 66 16","phoneVisible":false,"employer":{"translations":{"fr":{"id":27,"name":"Haute \u00e9cole de sant\u00e9 - Gen\u00e8ve"}},"id":569,"ldapId":"RORG-HEGE-HEDS","abbreviation":"HEDS-GE","link":"http:\/\/www.hesge.ch\/heds","mail":"rh-heds@hesge.ch ","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/logo_heds-ge.png","gmap":"46.191991, 6.153099","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1047,"type":"adressePrincipale","street":"Avenue de Champel 47","officeBox":"","country":"CH","city":"1206 Gen\u00e8ve"}],"mainDomain":null,"secondaryDomain":null,"programs":[{"id":19,"empty":false,"name":"BSc HES-SO en Soins infirmiers"},{"id":43,"empty":false,"name":"BSc HES-SO en Technique en radiologie m\u00e9dicale"},{"id":44,"empty":false,"name":"BSc HES-SO en Physioth\u00e9rapie"},{"id":45,"empty":false,"name":"BSc HES-SO en Nutrition et di\u00e9t\u00e9tique"},{"id":46,"empty":false,"name":"BSc HES-SO de Sage-femme"},{"id":71,"empty":false,"name":"European MSc en Midwifery"}]},"instituts":[],"service":{"translations":{"fr":{"id":27,"name":"Haute \u00e9cole de sant\u00e9 - Gen\u00e8ve"}},"id":569,"ldapId":"RORG-HEGE-HEDS","abbreviation":"HEDS-GE","link":"http:\/\/www.hesge.ch\/heds","mail":"rh-heds@hesge.ch ","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/logo_heds-ge.png","gmap":"46.191991, 6.153099","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1047,"type":"adressePrincipale","street":"Avenue de Champel 47","officeBox":"","country":"CH","city":"1206 Gen\u00e8ve"}],"mainDomain":null,"secondaryDomain":null,"programs":[{"id":19,"empty":false,"name":"BSc HES-SO en Soins infirmiers"},{"id":43,"empty":false,"name":"BSc HES-SO en Technique en radiologie m\u00e9dicale"},{"id":44,"empty":false,"name":"BSc HES-SO en Physioth\u00e9rapie"},{"id":45,"empty":false,"name":"BSc HES-SO en Nutrition et di\u00e9t\u00e9tique"},{"id":46,"empty":false,"name":"BSc HES-SO de Sage-femme"},{"id":71,"empty":false,"name":"European MSc en Midwifery"}]},"serviceHesso":null,"branch":{"translations":{"fr":{"id":503,"name":"Technique en radiologie m\u00e9dicale"}},"id":4416904,"abbreviation":"TRM","type":1,"ldapId":"RACA-SANT-TERM","parent":{"translations":{"fr":{"id":575,"name":"Sant\u00e9"}},"id":4408734,"abbreviation":"SANT","type":0,"ldapId":"RACA-SANT","parent":null}}},{"id":11890517207,"position":2,"master":0,"function":"","title":null,"email":"stavroula.pallada@hesge.ch","display":true,"jobLocation":null,"phone":"+41 22 558 66 16","phoneVisible":false,"employer":{"translations":{"fr":{"id":27,"name":"Haute \u00e9cole de sant\u00e9 - Gen\u00e8ve"}},"id":569,"ldapId":"RORG-HEGE-HEDS","abbreviation":"HEDS-GE","link":"http:\/\/www.hesge.ch\/heds","mail":"rh-heds@hesge.ch ","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/logo_heds-ge.png","gmap":"46.191991, 6.153099","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1047,"type":"adressePrincipale","street":"Avenue de Champel 47","officeBox":"","country":"CH","city":"1206 Gen\u00e8ve"}],"mainDomain":null,"secondaryDomain":null,"programs":[{"id":19,"empty":false,"name":"BSc HES-SO en Soins infirmiers"},{"id":43,"empty":false,"name":"BSc HES-SO en Technique en radiologie m\u00e9dicale"},{"id":44,"empty":false,"name":"BSc HES-SO en Physioth\u00e9rapie"},{"id":45,"empty":false,"name":"BSc HES-SO en Nutrition et di\u00e9t\u00e9tique"},{"id":46,"empty":false,"name":"BSc HES-SO de Sage-femme"},{"id":71,"empty":false,"name":"European MSc en Midwifery"}]},"instituts":[],"service":{"translations":{"fr":{"id":27,"name":"Haute \u00e9cole de sant\u00e9 - Gen\u00e8ve"}},"id":569,"ldapId":"RORG-HEGE-HEDS","abbreviation":"HEDS-GE","link":"http:\/\/www.hesge.ch\/heds","mail":"rh-heds@hesge.ch ","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/logo_heds-ge.png","gmap":"46.191991, 6.153099","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1047,"type":"adressePrincipale","street":"Avenue de Champel 47","officeBox":"","country":"CH","city":"1206 Gen\u00e8ve"}],"mainDomain":null,"secondaryDomain":null,"programs":[{"id":19,"empty":false,"name":"BSc HES-SO en Soins infirmiers"},{"id":43,"empty":false,"name":"BSc HES-SO en Technique en radiologie m\u00e9dicale"},{"id":44,"empty":false,"name":"BSc HES-SO en Physioth\u00e9rapie"},{"id":45,"empty":false,"name":"BSc HES-SO en Nutrition et di\u00e9t\u00e9tique"},{"id":46,"empty":false,"name":"BSc HES-SO de Sage-femme"},{"id":71,"empty":false,"name":"European MSc en Midwifery"}]},"serviceHesso":null,"branch":{"translations":{"fr":{"id":503,"name":"Technique en radiologie m\u00e9dicale"}},"id":4416904,"abbreviation":"TRM","type":1,"ldapId":"RACA-SANT-TERM","parent":{"translations":{"fr":{"id":575,"name":"Sant\u00e9"}},"id":4408734,"abbreviation":"SANT","type":0,"ldapId":"RACA-SANT","parent":null}}}]{"id":1056350,"translations":[],"program":{"id":43,"empty":false,"name":"BSc HES-SO en Technique en radiologie m\u00e9dicale"},"programText":"BSc HES-SO en Technique en radiologie m\u00e9dicale","level":null,"url":null,"display":true,"dataHub":false,"position":0,"unit":{"translations":{"fr":{"id":27,"name":"Haute \u00e9cole de sant\u00e9 - Gen\u00e8ve"}},"id":569,"ldapId":"RORG-HEGE-HEDS","abbreviation":"HEDS-GE","link":"http:\/\/www.hesge.ch\/heds","mail":"rh-heds@hesge.ch ","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/logo_heds-ge.png","gmap":"46.191991, 6.153099","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1047,"type":"adressePrincipale","street":"Avenue de Champel 47","officeBox":"","country":"CH","city":"1206 Gen\u00e8ve"}],"mainDomain":null,"secondaryDomain":null,"programs":[{"id":19,"empty":false,"name":"BSc HES-SO en Soins infirmiers"},{"id":43,"empty":false,"name":"BSc HES-SO en Technique en radiologie m\u00e9dicale"},{"id":44,"empty":false,"name":"BSc HES-SO en Physioth\u00e9rapie"},{"id":45,"empty":false,"name":"BSc HES-SO en Nutrition et di\u00e9t\u00e9tique"},{"id":46,"empty":false,"name":"BSc HES-SO de Sage-femme"},{"id":71,"empty":false,"name":"European MSc en Midwifery"}]},"unitText":"Haute \u00e9cole de sant\u00e9 - Gen\u00e8ve","executions":[{"id":501,"languages":["fr","en"],"allLanguages":true,"execution":{"id":46,"year":null,"semester":null,"branch":null,"slug":"e9b5bb507338c7a322fd09ec4489cb9c","title":"Radioprotection op\u00e9rationnelle"}},{"id":502,"languages":["fr","en"],"allLanguages":true,"execution":{"id":429,"year":null,"semester":null,"branch":null,"slug":"e789707cad47d5765bc1e70323c644c2","title":"Radioprotection en Physique Nucl\u00e9aire"}},{"id":3410,"languages":["fr","en"],"allLanguages":true,"execution":{"id":2411,"year":null,"semester":null,"branch":null,"slug":"5e0ff46a01180d703ce9323d4055251a","title":"Radiophysique"}},{"id":3411,"languages":["fr","en"],"allLanguages":true,"execution":{"id":2413,"year":null,"semester":null,"branch":null,"slug":"6d043d741061cbdedc3105e4a3cd87e7","title":"Dosimetrie"}},{"id":3412,"languages":["fr","en"],"allLanguages":true,"execution":{"id":2414,"year":null,"semester":null,"branch":null,"slug":"34d4fb01716fb16a90e09a761c7bb77a","title":"Mesures de radiations"}}]}{"id":1012989,"translations":[],"program":{"id":15,"empty":false,"name":"BSc HES-SO en Microtechniques"},"programText":"BSc HES-SO en Microtechniques","level":null,"url":null,"display":true,"dataHub":false,"position":0,"unit":{"translations":{"fr":{"id":23,"name":"Haute \u00e9cole du paysage, d'ing\u00e9nierie et d'architecture de Gen\u00e8ve"}},"id":561,"ldapId":"RORG-HEGE-EPIA","abbreviation":"hepia","link":"http:\/\/www.hesge.ch\/hepia","mail":"RHHEPIA@hesge.ch ","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/logo_hepia-ge.png","gmap":"46.209551, 6.135261","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1054,"type":"adressePrincipale","street":"Rue de la Prairie 4","officeBox":"","country":"CH","city":"1202 Gen\u00e8ve"}],"mainDomain":null,"secondaryDomain":null,"programs":[{"id":15,"empty":false,"name":"BSc HES-SO en Microtechniques"},{"id":22,"empty":false,"name":"BSc HES-SO en G\u00e9nie m\u00e9canique"},{"id":24,"empty":false,"name":"BSc HES-SO en G\u00e9nie civil"},{"id":26,"empty":false,"name":"BA HES-SO en Architecture"},{"id":49,"empty":false,"name":"BSc HES-SO en Technique des b\u00e2timents"},{"id":50,"empty":false,"name":"BSc HES-SO en Ing\u00e9nierie des technologies de l'information"},{"id":51,"empty":false,"name":"BSc HES-SO en Gestion de la nature"},{"id":52,"empty":false,"name":"BSc HES-SO en Architecture du paysage"},{"id":53,"empty":false,"name":"BSc HES-SO en Agronomie"},{"id":79,"empty":false,"name":"BSC HES-SO en Informatique et syst\u00e8mes de communication"},{"id":80,"empty":false,"name":"BSc en Informatique et syst\u00e8mes de communication"}]},"unitText":"Haute \u00e9cole du paysage, d'ing\u00e9nierie et d'architecture de Gen\u00e8ve","executions":[{"id":498,"languages":["fr","en","de"],"allLanguages":true,"execution":{"id":427,"year":null,"semester":null,"branch":null,"slug":"037eb5be6ffae7c0833dc0261365f25b","title":"Techniques d'Imagerie Biomedicale"}},{"id":499,"languages":["fr","en","de"],"allLanguages":true,"execution":{"id":428,"year":null,"semester":null,"branch":null,"slug":"d3f8f715aeb701188d8a6fe8f1293a47","title":"Simulations Monte Carlo"}},{"id":500,"languages":["fr","en","de"],"allLanguages":true,"execution":{"id":429,"year":null,"semester":null,"branch":null,"slug":"e789707cad47d5765bc1e70323c644c2","title":"Radioprotection en Physique Nucl\u00e9aire"}}]}{"id":1005374,"translations":[],"program":{"id":57,"empty":false,"name":"MSc HES-SO en Engineering"},"programText":"MSc HES-SO en Engineering","level":null,"url":null,"display":true,"dataHub":false,"position":1,"unit":{"translations":{"fr":{"id":4,"name":"HES-SO Master"}},"id":514047574,"ldapId":"RORG-MASO","abbreviation":"SO Master","type":{"id":3,"name":"Ecole membre"},"addresses":[{"id":1048,"type":"adressePrincipale","street":"Av. de Provence 6","officeBox":"","country":"CH","city":"1007 Lausanne"}],"mainDomain":null,"secondaryDomain":null,"link":"http:\/\/www.hes-so.ch\/masters","mail":"rh@hes-so.ch","logo":"http:\/\/people.hes-so.ch\/build\/img\/logos\/\/units-logos\/hes_so_logo_rgb-63a08f56cfb2b.png","gmap":"46.523196, 6.610416","programs":[{"id":54,"empty":false,"name":"MSc HES-SO\/UNIL en sciences infirmi\u00e8res"},{"id":55,"empty":false,"name":"MSc HES-SO en Business Administration"},{"id":56,"empty":false,"name":"MSc HES-SO en Life Sciences"},{"id":57,"empty":false,"name":"MSc HES-SO en Engineering"},{"id":58,"name":"MA BFH\/HES-SO en Architecture","empty":false},{"id":59,"empty":false,"name":"MSc HES-SO en Integrated Innovation for Product and Business Development - Innokick"},{"id":60,"empty":false,"name":"MSc HES-SO\/UNIL en Sciences de la sant\u00e9"},{"id":61,"empty":false,"name":"MA HES-SO en Travail social"},{"id":74,"empty":false,"name":"MSc HES-SO en Ing\u00e9nierie du territoire"},{"id":75,"empty":false,"name":"MSc UNIGE\/HES-SO en D\u00e9veloppement territorial"}]},"unitText":"HES-SO Master","executions":[{"id":3365,"languages":["fr","en"],"allLanguages":true,"execution":{"id":2415,"year":null,"semester":null,"branch":null,"slug":"025affed2f2d593ccd0dceaf0fbe34b3","title":"Energie Nucl\u00e9aire"}}]}{"id":1074897,"translations":[],"program":null,"programText":"Master en Sciences Biom\u00e9dicales","level":null,"url":null,"display":true,"dataHub":false,"position":1,"unit":null,"unitText":"University of Geneva (UNIGE)","executions":[{"id":3413,"languages":["fr","en"],"allLanguages":true,"execution":{"id":2416,"year":null,"semester":null,"branch":null,"slug":"ff5922e3627647b9c2b1a5e17d33111e","title":"Techniques d'imagerie Biom\u00e9dicale"}}]}{"id":3634,"languages":["fr"],"allLanguages":false,"skill":{"id":2302,"name":"Radioprotection"}}{"id":3635,"languages":["fr"],"allLanguages":false,"skill":{"id":2303,"name":"Physique M\u00e9dicale"}}{"id":3636,"languages":["fr"],"allLanguages":false,"skill":{"id":2304,"name":"Physique Nucl\u00e9aire"}}{"id":3637,"languages":["en"],"allLanguages":false,"skill":{"id":798,"name":"Applied Physics"}}{"id":3638,"languages":["fr"],"allLanguages":false,"skill":{"id":2305,"name":"Radiotherapie"}}{"id":3639,"languages":["en"],"allLanguages":false,"skill":{"id":2306,"name":"Simulations Monte Carlo"}}{"id":3640,"languages":["fr"],"allLanguages":false,"skill":{"id":2307,"name":"Resonnance Nucl\u00e9aire Magn\u00e9tique"}}{"id":3641,"languages":["fr","en","de"],"allLanguages":true,"skill":{"id":1337,"name":"IRM"}}{"id":3642,"languages":["fr"],"allLanguages":false,"skill":{"id":2308,"name":"Imagerie Biom\u00e9dicale"}}